Sol-Gel Technologies, Ltd.

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Generic Drugs
    • Drug Delivery
      • Topical Delivery
      • Controlled Release
  • Biotechnology

Other Names/Subsidiaries

  • Sol-Gel Technologies Ltd.
See more in Biomedtracker

Latest on Sol-Gel Technologies, Ltd.

Scrip

Deal Watch: Merck KGaA Enhances Cell/Gene Therapy Capabilities With Mirus Takeout

 
• By Joseph Haas, Vibha Ravi, and Dexter Jie Yan

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Merck KGaA Pays $600m For Transfection

Generics Bulletin

Padagis Hit With Immediate Suit After Filing First ANDA For US Zoryve Cream

 
• By Dean Rudge

Padagis may have to defend itself against alleged patent infringement in the US after filing the first abbreviated new drug application for a generic version of Arcutis Biotherapeutics’ Zoryve (roflu

Scrip

Deal Watch: Gurnet Point, Novo Holdings Buy Out Paratek

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Antibiotics Firm Agrees To Go Private F

Scrip

Deal Watch: Sol-Gel To Tackle Gorlin Syndrome In Pact With BridgeBio’s PellePharm

 
• By Joseph Haas, Lisa Takagi, and Dexter Jie Yan

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sol-Gel Hopes To Bring PellePharm’s Pat